Shanghai Clinical Cohort - Esophageal Cancer

N/ACompletedNCT07312526

Shanghai Chest Hospital2,116 enrolled

Overview

A prospective cohort of patients who received esophagectomy for esophageal cancer in participating centers.

Study Type

OBSERVATIONAL

Enrollment

2,116

Conditions

Esophageal Cancer Esophagectomy

Interventions

esophagectomyPROCEDURE

esophagectomy

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Received esophagectomy in these centers for esophageal cancer. Exclusion Criteria: * No esophagectomy.

Locations (1)

Shanghai Chest Hospital

Shanghai, China

Outcomes

Primary Outcomes

Overal survival

Time frame: From the date of enrollment until the date of death or loss of follow-up, assessed up to 10 years. Follow-up is scheduled every 3 months in the first 2 years. Every 6 months from the 2nd to the 5th year. Then once a year. Until death or loss of follow.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.